Mikael Dolsten Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

RCKT Quotes by TradingView

Mikael Dolsten is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 44,220 shares of RCKT, which is worth approximately $128,680. The most recent transaction as insider was on Jun 18, 2025, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.2K
210.97% 3M change
n/a 12M change
Total Value Held $128,680

Mikael Dolsten Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Grant, award, or other acquisition
-
30,000 Added 40.42%
44,220 Common Stock
Mar 05 2025
BUY
Other acquisition or disposition
-
14,220 Added 50.0%
14,220 Common Stock

Also insider at

PFE
PFIZER INC Healthcare
President R&D
A
AGILENT TECHNOLOGIES, INC. Healthcare
Director
KPTI
Karyopharm Therapeutics Inc. Healthcare
Director
MD

Mikael Dolsten

New York, NY

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RCKT